Inrebic Approval Is A Boost For Myelofibrosis And Celgene's Buyer Bristol

Diagnosis of Myelofibrosis. Laboratory blood bottle (tube), glass slide with blood smear, hematology test, stethoscope lying on notebook with printed text hematological diagnosis of Myelofibrosis - Image
Inrebic is only the second drug, after Jakafi, approved for myelofibrosis in the US. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip